Oct 29, 2021· Comment from American Pharmacists Association (APhA)· FDA-2021-N-0891-0019
Please see the American Pharmacists Association's (APhA) attached comments on PDUFA VII.
FDANonrulemakingFDA-2021-N-0891
Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments
RIN
—
Last modified
Mar 29, 2022
Comment window
closed 1734d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Oct 29, 2021 and Oct 29, 2021. 13 other organizations filed here. The comment window closed 1734d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (13)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- a center of the Milken Institutetrade assoc.1 filing · confidence 85%
- Alliance for Aging Researchtrade assoc.1 filing · confidence 85%
- Alliance for Regenerative Medicine - Washingtontrade assoc.1 filing · confidence 85%
- American Society of Gene & Cell Therapytrade assoc.1 filing · confidence 85%
- EveryLife Foundation for Rare Diseasestrade assoc.1 filing · confidence 85%
- LUNGevity Foundationtrade assoc.1 filing · confidence 85%
- Lupus Foundation of Americatrade assoc.1 filing · confidence 85%
- Muscular Dystrophy Associationtrade assoc.1 filing · confidence 85%
- National Alliance for Caregivingtrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Physicians Committee for Responsible Medicinetrade assoc.1 filing · confidence 85%
- The RWE Alliancetrade assoc.1 filing · confidence 85%
- Vizient Inc.unverified attribution1 filing · confidence 70%